NCT04568707

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 238 (actual)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients with neurological or psychiatric symptoms or pre-existing disease will be sampled (blood for serum and DNA or saliva for DNA) at inclusion and at M6 (blood) and M12 (blood) depending on their pathology. Sampling will be done either at hospital if patient is on site for routine care or at home if no consultation is scheduled at hospital.

Conditions

• Covid19
• Neurologic Manifestations
• Psychiatric Manifestations

Interventions

Type	Name	Description
OTHER	blood sample	blood sample for serum (serology, biomarkers) and DNA

Timeline

• Start date: 2020-10-23
• Primary completion: 2022-12-14
• Completion: 2022-12-14
• First posted: 2020-09-29
• Last updated: 2024-02-02

Locations

1 site across 1 country: France